Global Long-acting GLP-1RA Market Growth 2026-2032
The global Long-acting GLP-1RA market size is predicted to grow from US$ 20900 million in 2025 to US$ 34980 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032.
A long-acting GLP-1RA, or Long-acting Glucagon-Like Peptide-1 Receptor Agonist, is a medication designed for the treatment of type 2 diabetes and, in some cases, obesity. It is characterized by an extended half-life, typically requiring only once-weekly injections. Long-acting GLP-1RAs have the ability to enhance insulin secretion from the pancreas and reduce the release of glucagon, thereby lowering post-meal blood sugar levels. Furthermore, they are effective at reducing fasting blood sugar levels and have a more pronounced effect on weight loss.
Long-acting GLP-1RA (Glucagon-Like Peptide-1 Receptor Agonist) is experiencing rapid growth in the diabetes treatment sector. The market size is continually expanding, with increasing sales demonstrating its significant potential. Long-acting GLP-1RA medications are favored for their unique effects in improving blood sugar control while aiding in weight reduction, gradually becoming a mainstream choice for type 2 diabetes treatment. Beyond glucose regulation, their specific uses extend to assisting patients in achieving weight management goals. In the future, long-acting GLP-1RA is poised to optimize formulations, mitigate side effects, and broaden its reach to a more diverse patient population, offering more effective and personalized treatment options for diabetes patients worldwide.
LP Information, Inc. (LPI) ' newest research report, the “Long-acting GLP-1RA Industry Forecast” looks at past sales and reviews total world Long-acting GLP-1RA sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting GLP-1RA sales for 2026 through 2032. With Long-acting GLP-1RA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting GLP-1RA industry.
This Insight Report provides a comprehensive analysis of the global Long-acting GLP-1RA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-acting GLP-1RA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting GLP-1RA market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting GLP-1RA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting GLP-1RA.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting GLP-1RA market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
A long-acting GLP-1RA, or Long-acting Glucagon-Like Peptide-1 Receptor Agonist, is a medication designed for the treatment of type 2 diabetes and, in some cases, obesity. It is characterized by an extended half-life, typically requiring only once-weekly injections. Long-acting GLP-1RAs have the ability to enhance insulin secretion from the pancreas and reduce the release of glucagon, thereby lowering post-meal blood sugar levels. Furthermore, they are effective at reducing fasting blood sugar levels and have a more pronounced effect on weight loss.
Long-acting GLP-1RA (Glucagon-Like Peptide-1 Receptor Agonist) is experiencing rapid growth in the diabetes treatment sector. The market size is continually expanding, with increasing sales demonstrating its significant potential. Long-acting GLP-1RA medications are favored for their unique effects in improving blood sugar control while aiding in weight reduction, gradually becoming a mainstream choice for type 2 diabetes treatment. Beyond glucose regulation, their specific uses extend to assisting patients in achieving weight management goals. In the future, long-acting GLP-1RA is poised to optimize formulations, mitigate side effects, and broaden its reach to a more diverse patient population, offering more effective and personalized treatment options for diabetes patients worldwide.
LP Information, Inc. (LPI) ' newest research report, the “Long-acting GLP-1RA Industry Forecast” looks at past sales and reviews total world Long-acting GLP-1RA sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-acting GLP-1RA sales for 2026 through 2032. With Long-acting GLP-1RA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-acting GLP-1RA industry.
This Insight Report provides a comprehensive analysis of the global Long-acting GLP-1RA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-acting GLP-1RA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-acting GLP-1RA market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-acting GLP-1RA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-acting GLP-1RA.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-acting GLP-1RA market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Liraglutide
- Albiglutide
- Dulaglutide
- Semaglutide
- Polyethylene Glycol Loxenatide
- Exenatide Microspheres
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- GSK
- Novo Nordisk
- AstraZeneca
- Eli Lily
- Hansoh Pharmaceutical
- What is the 10-year outlook for the global Long-acting GLP-1RA market?
- What factors are driving Long-acting GLP-1RA market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Long-acting GLP-1RA market opportunities vary by end market size?
- How does Long-acting GLP-1RA break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting GLP-1RA Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-acting GLP-1RA by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-acting GLP-1RA by Country/Region, 2021, 2025 & 2032
2.2 Long-acting GLP-1RA Segment by Type
2.2.1 Liraglutide
2.2.2 Albiglutide
2.2.3 Dulaglutide
2.2.4 Semaglutide
2.2.5 Polyethylene Glycol Loxenatide
2.2.6 Exenatide Microspheres
2.2.7 Long-acting GLP-1RA Sales by Type
2.2.7.1 Global Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
2.2.7.2 Global Long-acting GLP-1RA Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Long-acting GLP-1RA Sale Price by Type (2021-2026)
2.3 Long-acting GLP-1RA Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Long-acting GLP-1RA Sales by Application
2.3.4.1 Global Long-acting GLP-1RA Sale Market Share by Application (2021-2026)
2.3.4.2 Global Long-acting GLP-1RA Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Long-acting GLP-1RA Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-acting GLP-1RA Breakdown Data by Company
3.1.1 Global Long-acting GLP-1RA Annual Sales by Company (2021-2026)
3.1.2 Global Long-acting GLP-1RA Sales Market Share by Company (2021-2026)
3.2 Global Long-acting GLP-1RA Annual Revenue by Company (2021-2026)
3.2.1 Global Long-acting GLP-1RA Revenue by Company (2021-2026)
3.2.2 Global Long-acting GLP-1RA Revenue Market Share by Company (2021-2026)
3.3 Global Long-acting GLP-1RA Sale Price by Company
3.4 Key Manufacturers Long-acting GLP-1RA Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting GLP-1RA Product Location Distribution
3.4.2 Players Long-acting GLP-1RA Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING GLP-1RA BY GEOGRAPHIC REGION
4.1 World Historic Long-acting GLP-1RA Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-acting GLP-1RA Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-acting GLP-1RA Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-acting GLP-1RA Market Size by Country/Region (2021-2026)
4.2.1 Global Long-acting GLP-1RA Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-acting GLP-1RA Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting GLP-1RA Sales Growth
4.4 APAC Long-acting GLP-1RA Sales Growth
4.5 Europe Long-acting GLP-1RA Sales Growth
4.6 Middle East & Africa Long-acting GLP-1RA Sales Growth
5 AMERICAS
5.1 Americas Long-acting GLP-1RA Sales by Country
5.1.1 Americas Long-acting GLP-1RA Sales by Country (2021-2026)
5.1.2 Americas Long-acting GLP-1RA Revenue by Country (2021-2026)
5.2 Americas Long-acting GLP-1RA Sales by Type (2021-2026)
5.3 Americas Long-acting GLP-1RA Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting GLP-1RA Sales by Region
6.1.1 APAC Long-acting GLP-1RA Sales by Region (2021-2026)
6.1.2 APAC Long-acting GLP-1RA Revenue by Region (2021-2026)
6.2 APAC Long-acting GLP-1RA Sales by Type (2021-2026)
6.3 APAC Long-acting GLP-1RA Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting GLP-1RA by Country
7.1.1 Europe Long-acting GLP-1RA Sales by Country (2021-2026)
7.1.2 Europe Long-acting GLP-1RA Revenue by Country (2021-2026)
7.2 Europe Long-acting GLP-1RA Sales by Type (2021-2026)
7.3 Europe Long-acting GLP-1RA Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting GLP-1RA by Country
8.1.1 Middle East & Africa Long-acting GLP-1RA Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-acting GLP-1RA Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-acting GLP-1RA Sales by Type (2021-2026)
8.3 Middle East & Africa Long-acting GLP-1RA Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting GLP-1RA
10.3 Manufacturing Process Analysis of Long-acting GLP-1RA
10.4 Industry Chain Structure of Long-acting GLP-1RA
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting GLP-1RA Distributors
11.3 Long-acting GLP-1RA Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING GLP-1RA BY GEOGRAPHIC REGION
12.1 Global Long-acting GLP-1RA Market Size Forecast by Region
12.1.1 Global Long-acting GLP-1RA Forecast by Region (2027-2032)
12.1.2 Global Long-acting GLP-1RA Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-acting GLP-1RA Forecast by Type (2027-2032)
12.7 Global Long-acting GLP-1RA Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
13.1.3 Novo Nordisk Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Long-acting GLP-1RA Product Portfolios and Specifications
13.2.3 GSK Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Novo Nordisk
13.3.1 Novo Nordisk Company Information
13.3.2 Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
13.3.3 Novo Nordisk Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novo Nordisk Main Business Overview
13.3.5 Novo Nordisk Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Long-acting GLP-1RA Product Portfolios and Specifications
13.4.3 AstraZeneca Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Eli Lily
13.5.1 Eli Lily Company Information
13.5.2 Eli Lily Long-acting GLP-1RA Product Portfolios and Specifications
13.5.3 Eli Lily Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Eli Lily Main Business Overview
13.5.5 Eli Lily Latest Developments
13.6 Hansoh Pharmaceutical
13.6.1 Hansoh Pharmaceutical Company Information
13.6.2 Hansoh Pharmaceutical Long-acting GLP-1RA Product Portfolios and Specifications
13.6.3 Hansoh Pharmaceutical Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hansoh Pharmaceutical Main Business Overview
13.6.5 Hansoh Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-acting GLP-1RA Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-acting GLP-1RA by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-acting GLP-1RA by Country/Region, 2021, 2025 & 2032
2.2 Long-acting GLP-1RA Segment by Type
2.2.1 Liraglutide
2.2.2 Albiglutide
2.2.3 Dulaglutide
2.2.4 Semaglutide
2.2.5 Polyethylene Glycol Loxenatide
2.2.6 Exenatide Microspheres
2.2.7 Long-acting GLP-1RA Sales by Type
2.2.7.1 Global Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
2.2.7.2 Global Long-acting GLP-1RA Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Long-acting GLP-1RA Sale Price by Type (2021-2026)
2.3 Long-acting GLP-1RA Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Long-acting GLP-1RA Sales by Application
2.3.4.1 Global Long-acting GLP-1RA Sale Market Share by Application (2021-2026)
2.3.4.2 Global Long-acting GLP-1RA Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Long-acting GLP-1RA Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-acting GLP-1RA Breakdown Data by Company
3.1.1 Global Long-acting GLP-1RA Annual Sales by Company (2021-2026)
3.1.2 Global Long-acting GLP-1RA Sales Market Share by Company (2021-2026)
3.2 Global Long-acting GLP-1RA Annual Revenue by Company (2021-2026)
3.2.1 Global Long-acting GLP-1RA Revenue by Company (2021-2026)
3.2.2 Global Long-acting GLP-1RA Revenue Market Share by Company (2021-2026)
3.3 Global Long-acting GLP-1RA Sale Price by Company
3.4 Key Manufacturers Long-acting GLP-1RA Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-acting GLP-1RA Product Location Distribution
3.4.2 Players Long-acting GLP-1RA Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING GLP-1RA BY GEOGRAPHIC REGION
4.1 World Historic Long-acting GLP-1RA Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-acting GLP-1RA Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-acting GLP-1RA Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-acting GLP-1RA Market Size by Country/Region (2021-2026)
4.2.1 Global Long-acting GLP-1RA Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-acting GLP-1RA Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-acting GLP-1RA Sales Growth
4.4 APAC Long-acting GLP-1RA Sales Growth
4.5 Europe Long-acting GLP-1RA Sales Growth
4.6 Middle East & Africa Long-acting GLP-1RA Sales Growth
5 AMERICAS
5.1 Americas Long-acting GLP-1RA Sales by Country
5.1.1 Americas Long-acting GLP-1RA Sales by Country (2021-2026)
5.1.2 Americas Long-acting GLP-1RA Revenue by Country (2021-2026)
5.2 Americas Long-acting GLP-1RA Sales by Type (2021-2026)
5.3 Americas Long-acting GLP-1RA Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-acting GLP-1RA Sales by Region
6.1.1 APAC Long-acting GLP-1RA Sales by Region (2021-2026)
6.1.2 APAC Long-acting GLP-1RA Revenue by Region (2021-2026)
6.2 APAC Long-acting GLP-1RA Sales by Type (2021-2026)
6.3 APAC Long-acting GLP-1RA Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-acting GLP-1RA by Country
7.1.1 Europe Long-acting GLP-1RA Sales by Country (2021-2026)
7.1.2 Europe Long-acting GLP-1RA Revenue by Country (2021-2026)
7.2 Europe Long-acting GLP-1RA Sales by Type (2021-2026)
7.3 Europe Long-acting GLP-1RA Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-acting GLP-1RA by Country
8.1.1 Middle East & Africa Long-acting GLP-1RA Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-acting GLP-1RA Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-acting GLP-1RA Sales by Type (2021-2026)
8.3 Middle East & Africa Long-acting GLP-1RA Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-acting GLP-1RA
10.3 Manufacturing Process Analysis of Long-acting GLP-1RA
10.4 Industry Chain Structure of Long-acting GLP-1RA
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-acting GLP-1RA Distributors
11.3 Long-acting GLP-1RA Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING GLP-1RA BY GEOGRAPHIC REGION
12.1 Global Long-acting GLP-1RA Market Size Forecast by Region
12.1.1 Global Long-acting GLP-1RA Forecast by Region (2027-2032)
12.1.2 Global Long-acting GLP-1RA Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-acting GLP-1RA Forecast by Type (2027-2032)
12.7 Global Long-acting GLP-1RA Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
13.1.3 Novo Nordisk Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Long-acting GLP-1RA Product Portfolios and Specifications
13.2.3 GSK Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Novo Nordisk
13.3.1 Novo Nordisk Company Information
13.3.2 Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
13.3.3 Novo Nordisk Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novo Nordisk Main Business Overview
13.3.5 Novo Nordisk Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Long-acting GLP-1RA Product Portfolios and Specifications
13.4.3 AstraZeneca Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Eli Lily
13.5.1 Eli Lily Company Information
13.5.2 Eli Lily Long-acting GLP-1RA Product Portfolios and Specifications
13.5.3 Eli Lily Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Eli Lily Main Business Overview
13.5.5 Eli Lily Latest Developments
13.6 Hansoh Pharmaceutical
13.6.1 Hansoh Pharmaceutical Company Information
13.6.2 Hansoh Pharmaceutical Long-acting GLP-1RA Product Portfolios and Specifications
13.6.3 Hansoh Pharmaceutical Long-acting GLP-1RA Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hansoh Pharmaceutical Main Business Overview
13.6.5 Hansoh Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-acting GLP-1RA Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-acting GLP-1RA Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liraglutide
Table 4. Major Players of Albiglutide
Table 5. Major Players of Dulaglutide
Table 6. Major Players of Semaglutide
Table 7. Major Players of Polyethylene Glycol Loxenatide
Table 8. Major Players of Exenatide Microspheres
Table 9. Global Long-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 10. Global Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
Table 11. Global Long-acting GLP-1RA Revenue by Type (2021-2026) & ($ million)
Table 12. Global Long-acting GLP-1RA Revenue Market Share by Type (2021-2026)
Table 13. Global Long-acting GLP-1RA Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Long-acting GLP-1RA Sale by Application (2021-2026) & (K Units)
Table 15. Global Long-acting GLP-1RA Sale Market Share by Application (2021-2026)
Table 16. Global Long-acting GLP-1RA Revenue by Application (2021-2026) & ($ million)
Table 17. Global Long-acting GLP-1RA Revenue Market Share by Application (2021-2026)
Table 18. Global Long-acting GLP-1RA Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Long-acting GLP-1RA Sales by Company (2021-2026) & (K Units)
Table 20. Global Long-acting GLP-1RA Sales Market Share by Company (2021-2026)
Table 21. Global Long-acting GLP-1RA Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Long-acting GLP-1RA Revenue Market Share by Company (2021-2026)
Table 23. Global Long-acting GLP-1RA Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Long-acting GLP-1RA Producing Area Distribution and Sales Area
Table 25. Players Long-acting GLP-1RA Products Offered
Table 26. Long-acting GLP-1RA Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Long-acting GLP-1RA Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Long-acting GLP-1RA Sales Market Share Geographic Region (2021-2026)
Table 31. Global Long-acting GLP-1RA Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Long-acting GLP-1RA Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Long-acting GLP-1RA Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Long-acting GLP-1RA Sales Market Share by Country/Region (2021-2026)
Table 35. Global Long-acting GLP-1RA Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Long-acting GLP-1RA Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Long-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 38. Americas Long-acting GLP-1RA Sales Market Share by Country (2021-2026)
Table 39. Americas Long-acting GLP-1RA Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Long-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 41. Americas Long-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 42. APAC Long-acting GLP-1RA Sales by Region (2021-2026) & (K Units)
Table 43. APAC Long-acting GLP-1RA Sales Market Share by Region (2021-2026)
Table 44. APAC Long-acting GLP-1RA Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Long-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 46. APAC Long-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 47. Europe Long-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 48. Europe Long-acting GLP-1RA Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Long-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 50. Europe Long-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Long-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Long-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Long-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Long-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Long-acting GLP-1RA
Table 56. Key Market Challenges & Risks of Long-acting GLP-1RA
Table 57. Key Industry Trends of Long-acting GLP-1RA
Table 58. Long-acting GLP-1RA Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Long-acting GLP-1RA Distributors List
Table 61. Long-acting GLP-1RA Customer List
Table 62. Global Long-acting GLP-1RA Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Long-acting GLP-1RA Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Long-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Long-acting GLP-1RA Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Long-acting GLP-1RA Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Long-acting GLP-1RA Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Long-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Long-acting GLP-1RA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Long-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Long-acting GLP-1RA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Long-acting GLP-1RA Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Long-acting GLP-1RA Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Long-acting GLP-1RA Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Long-acting GLP-1RA Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Novo Nordisk Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 77. Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
Table 78. Novo Nordisk Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Novo Nordisk Main Business
Table 80. Novo Nordisk Latest Developments
Table 81. GSK Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 82. GSK Long-acting GLP-1RA Product Portfolios and Specifications
Table 83. GSK Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. GSK Main Business
Table 85. GSK Latest Developments
Table 86. Novo Nordisk Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 87. Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
Table 88. Novo Nordisk Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Novo Nordisk Main Business
Table 90. Novo Nordisk Latest Developments
Table 91. AstraZeneca Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 92. AstraZeneca Long-acting GLP-1RA Product Portfolios and Specifications
Table 93. AstraZeneca Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. AstraZeneca Main Business
Table 95. AstraZeneca Latest Developments
Table 96. Eli Lily Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 97. Eli Lily Long-acting GLP-1RA Product Portfolios and Specifications
Table 98. Eli Lily Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Eli Lily Main Business
Table 100. Eli Lily Latest Developments
Table 101. Hansoh Pharmaceutical Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 102. Hansoh Pharmaceutical Long-acting GLP-1RA Product Portfolios and Specifications
Table 103. Hansoh Pharmaceutical Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Hansoh Pharmaceutical Main Business
Table 105. Hansoh Pharmaceutical Latest Developments
Table 1. Long-acting GLP-1RA Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-acting GLP-1RA Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liraglutide
Table 4. Major Players of Albiglutide
Table 5. Major Players of Dulaglutide
Table 6. Major Players of Semaglutide
Table 7. Major Players of Polyethylene Glycol Loxenatide
Table 8. Major Players of Exenatide Microspheres
Table 9. Global Long-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 10. Global Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
Table 11. Global Long-acting GLP-1RA Revenue by Type (2021-2026) & ($ million)
Table 12. Global Long-acting GLP-1RA Revenue Market Share by Type (2021-2026)
Table 13. Global Long-acting GLP-1RA Sale Price by Type (2021-2026) & (US$/Unit)
Table 14. Global Long-acting GLP-1RA Sale by Application (2021-2026) & (K Units)
Table 15. Global Long-acting GLP-1RA Sale Market Share by Application (2021-2026)
Table 16. Global Long-acting GLP-1RA Revenue by Application (2021-2026) & ($ million)
Table 17. Global Long-acting GLP-1RA Revenue Market Share by Application (2021-2026)
Table 18. Global Long-acting GLP-1RA Sale Price by Application (2021-2026) & (US$/Unit)
Table 19. Global Long-acting GLP-1RA Sales by Company (2021-2026) & (K Units)
Table 20. Global Long-acting GLP-1RA Sales Market Share by Company (2021-2026)
Table 21. Global Long-acting GLP-1RA Revenue by Company (2021-2026) & ($ millions)
Table 22. Global Long-acting GLP-1RA Revenue Market Share by Company (2021-2026)
Table 23. Global Long-acting GLP-1RA Sale Price by Company (2021-2026) & (US$/Unit)
Table 24. Key Manufacturers Long-acting GLP-1RA Producing Area Distribution and Sales Area
Table 25. Players Long-acting GLP-1RA Products Offered
Table 26. Long-acting GLP-1RA Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Long-acting GLP-1RA Sales by Geographic Region (2021-2026) & (K Units)
Table 30. Global Long-acting GLP-1RA Sales Market Share Geographic Region (2021-2026)
Table 31. Global Long-acting GLP-1RA Revenue by Geographic Region (2021-2026) & ($ millions)
Table 32. Global Long-acting GLP-1RA Revenue Market Share by Geographic Region (2021-2026)
Table 33. Global Long-acting GLP-1RA Sales by Country/Region (2021-2026) & (K Units)
Table 34. Global Long-acting GLP-1RA Sales Market Share by Country/Region (2021-2026)
Table 35. Global Long-acting GLP-1RA Revenue by Country/Region (2021-2026) & ($ millions)
Table 36. Global Long-acting GLP-1RA Revenue Market Share by Country/Region (2021-2026)
Table 37. Americas Long-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 38. Americas Long-acting GLP-1RA Sales Market Share by Country (2021-2026)
Table 39. Americas Long-acting GLP-1RA Revenue by Country (2021-2026) & ($ millions)
Table 40. Americas Long-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 41. Americas Long-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 42. APAC Long-acting GLP-1RA Sales by Region (2021-2026) & (K Units)
Table 43. APAC Long-acting GLP-1RA Sales Market Share by Region (2021-2026)
Table 44. APAC Long-acting GLP-1RA Revenue by Region (2021-2026) & ($ millions)
Table 45. APAC Long-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 46. APAC Long-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 47. Europe Long-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 48. Europe Long-acting GLP-1RA Revenue by Country (2021-2026) & ($ millions)
Table 49. Europe Long-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 50. Europe Long-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 51. Middle East & Africa Long-acting GLP-1RA Sales by Country (2021-2026) & (K Units)
Table 52. Middle East & Africa Long-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Table 53. Middle East & Africa Long-acting GLP-1RA Sales by Type (2021-2026) & (K Units)
Table 54. Middle East & Africa Long-acting GLP-1RA Sales by Application (2021-2026) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Long-acting GLP-1RA
Table 56. Key Market Challenges & Risks of Long-acting GLP-1RA
Table 57. Key Industry Trends of Long-acting GLP-1RA
Table 58. Long-acting GLP-1RA Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Long-acting GLP-1RA Distributors List
Table 61. Long-acting GLP-1RA Customer List
Table 62. Global Long-acting GLP-1RA Sales Forecast by Region (2027-2032) & (K Units)
Table 63. Global Long-acting GLP-1RA Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Americas Long-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Americas Long-acting GLP-1RA Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. APAC Long-acting GLP-1RA Sales Forecast by Region (2027-2032) & (K Units)
Table 67. APAC Long-acting GLP-1RA Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 68. Europe Long-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Europe Long-acting GLP-1RA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Middle East & Africa Long-acting GLP-1RA Sales Forecast by Country (2027-2032) & (K Units)
Table 71. Middle East & Africa Long-acting GLP-1RA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. Global Long-acting GLP-1RA Sales Forecast by Type (2027-2032) & (K Units)
Table 73. Global Long-acting GLP-1RA Revenue Forecast by Type (2027-2032) & ($ millions)
Table 74. Global Long-acting GLP-1RA Sales Forecast by Application (2027-2032) & (K Units)
Table 75. Global Long-acting GLP-1RA Revenue Forecast by Application (2027-2032) & ($ millions)
Table 76. Novo Nordisk Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 77. Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
Table 78. Novo Nordisk Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Novo Nordisk Main Business
Table 80. Novo Nordisk Latest Developments
Table 81. GSK Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 82. GSK Long-acting GLP-1RA Product Portfolios and Specifications
Table 83. GSK Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. GSK Main Business
Table 85. GSK Latest Developments
Table 86. Novo Nordisk Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 87. Novo Nordisk Long-acting GLP-1RA Product Portfolios and Specifications
Table 88. Novo Nordisk Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Novo Nordisk Main Business
Table 90. Novo Nordisk Latest Developments
Table 91. AstraZeneca Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 92. AstraZeneca Long-acting GLP-1RA Product Portfolios and Specifications
Table 93. AstraZeneca Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. AstraZeneca Main Business
Table 95. AstraZeneca Latest Developments
Table 96. Eli Lily Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 97. Eli Lily Long-acting GLP-1RA Product Portfolios and Specifications
Table 98. Eli Lily Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Eli Lily Main Business
Table 100. Eli Lily Latest Developments
Table 101. Hansoh Pharmaceutical Basic Information, Long-acting GLP-1RA Manufacturing Base, Sales Area and Its Competitors
Table 102. Hansoh Pharmaceutical Long-acting GLP-1RA Product Portfolios and Specifications
Table 103. Hansoh Pharmaceutical Long-acting GLP-1RA Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Hansoh Pharmaceutical Main Business
Table 105. Hansoh Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-acting GLP-1RA
Figure 2. Long-acting GLP-1RA Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting GLP-1RA Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-acting GLP-1RA Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-acting GLP-1RA Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-acting GLP-1RA Sales Market Share by Country/Region (2025)
Figure 10. Long-acting GLP-1RA Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Liraglutide
Figure 12. Product Picture of Albiglutide
Figure 13. Product Picture of Dulaglutide
Figure 14. Product Picture of Semaglutide
Figure 15. Product Picture of Polyethylene Glycol Loxenatide
Figure 16. Product Picture of Exenatide Microspheres
Figure 17. Global Long-acting GLP-1RA Sales Market Share by Type in 2026
Figure 18. Global Long-acting GLP-1RA Revenue Market Share by Type (2021-2026)
Figure 19. Long-acting GLP-1RA Consumed in Hospital
Figure 20. Global Long-acting GLP-1RA Market: Hospital (2021-2026) & (K Units)
Figure 21. Long-acting GLP-1RA Consumed in Clinic
Figure 22. Global Long-acting GLP-1RA Market: Clinic (2021-2026) & (K Units)
Figure 23. Long-acting GLP-1RA Consumed in Other
Figure 24. Global Long-acting GLP-1RA Market: Other (2021-2026) & (K Units)
Figure 25. Global Long-acting GLP-1RA Sale Market Share by Application (2025)
Figure 26. Global Long-acting GLP-1RA Revenue Market Share by Application in 2026
Figure 27. Long-acting GLP-1RA Sales by Company in 2026 (K Units)
Figure 28. Global Long-acting GLP-1RA Sales Market Share by Company in 2026
Figure 29. Long-acting GLP-1RA Revenue by Company in 2026 ($ millions)
Figure 30. Global Long-acting GLP-1RA Revenue Market Share by Company in 2026
Figure 31. Global Long-acting GLP-1RA Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Long-acting GLP-1RA Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Long-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 34. Americas Long-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 35. APAC Long-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 36. APAC Long-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 37. Europe Long-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 38. Europe Long-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Long-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Long-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 41. Americas Long-acting GLP-1RA Sales Market Share by Country in 2026
Figure 42. Americas Long-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Figure 43. Americas Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 44. Americas Long-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 45. United States Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Long-acting GLP-1RA Sales Market Share by Region in 2026
Figure 50. APAC Long-acting GLP-1RA Revenue Market Share by Region (2021-2026)
Figure 51. APAC Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 52. APAC Long-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 53. China Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 57. India Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Long-acting GLP-1RA Sales Market Share by Country in 2026
Figure 61. Europe Long-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Figure 62. Europe Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 63. Europe Long-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 64. Germany Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 65. France Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 72. Egypt Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Long-acting GLP-1RA in 2026
Figure 78. Manufacturing Process Analysis of Long-acting GLP-1RA
Figure 79. Industry Chain Structure of Long-acting GLP-1RA
Figure 80. Channels of Distribution
Figure 81. Global Long-acting GLP-1RA Sales Market Forecast by Region (2027-2032)
Figure 82. Global Long-acting GLP-1RA Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Long-acting GLP-1RA Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Long-acting GLP-1RA Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Long-acting GLP-1RA Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Long-acting GLP-1RA Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Long-acting GLP-1RA
Figure 2. Long-acting GLP-1RA Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-acting GLP-1RA Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-acting GLP-1RA Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-acting GLP-1RA Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-acting GLP-1RA Sales Market Share by Country/Region (2025)
Figure 10. Long-acting GLP-1RA Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Liraglutide
Figure 12. Product Picture of Albiglutide
Figure 13. Product Picture of Dulaglutide
Figure 14. Product Picture of Semaglutide
Figure 15. Product Picture of Polyethylene Glycol Loxenatide
Figure 16. Product Picture of Exenatide Microspheres
Figure 17. Global Long-acting GLP-1RA Sales Market Share by Type in 2026
Figure 18. Global Long-acting GLP-1RA Revenue Market Share by Type (2021-2026)
Figure 19. Long-acting GLP-1RA Consumed in Hospital
Figure 20. Global Long-acting GLP-1RA Market: Hospital (2021-2026) & (K Units)
Figure 21. Long-acting GLP-1RA Consumed in Clinic
Figure 22. Global Long-acting GLP-1RA Market: Clinic (2021-2026) & (K Units)
Figure 23. Long-acting GLP-1RA Consumed in Other
Figure 24. Global Long-acting GLP-1RA Market: Other (2021-2026) & (K Units)
Figure 25. Global Long-acting GLP-1RA Sale Market Share by Application (2025)
Figure 26. Global Long-acting GLP-1RA Revenue Market Share by Application in 2026
Figure 27. Long-acting GLP-1RA Sales by Company in 2026 (K Units)
Figure 28. Global Long-acting GLP-1RA Sales Market Share by Company in 2026
Figure 29. Long-acting GLP-1RA Revenue by Company in 2026 ($ millions)
Figure 30. Global Long-acting GLP-1RA Revenue Market Share by Company in 2026
Figure 31. Global Long-acting GLP-1RA Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global Long-acting GLP-1RA Revenue Market Share by Geographic Region in 2026
Figure 33. Americas Long-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 34. Americas Long-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 35. APAC Long-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 36. APAC Long-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 37. Europe Long-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 38. Europe Long-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa Long-acting GLP-1RA Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa Long-acting GLP-1RA Revenue 2021-2026 ($ millions)
Figure 41. Americas Long-acting GLP-1RA Sales Market Share by Country in 2026
Figure 42. Americas Long-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Figure 43. Americas Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 44. Americas Long-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 45. United States Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC Long-acting GLP-1RA Sales Market Share by Region in 2026
Figure 50. APAC Long-acting GLP-1RA Revenue Market Share by Region (2021-2026)
Figure 51. APAC Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 52. APAC Long-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 53. China Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 57. India Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe Long-acting GLP-1RA Sales Market Share by Country in 2026
Figure 61. Europe Long-acting GLP-1RA Revenue Market Share by Country (2021-2026)
Figure 62. Europe Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 63. Europe Long-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 64. Germany Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 65. France Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 66. UK Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa Long-acting GLP-1RA Sales Market Share by Application (2021-2026)
Figure 72. Egypt Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries Long-acting GLP-1RA Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Long-acting GLP-1RA in 2026
Figure 78. Manufacturing Process Analysis of Long-acting GLP-1RA
Figure 79. Industry Chain Structure of Long-acting GLP-1RA
Figure 80. Channels of Distribution
Figure 81. Global Long-acting GLP-1RA Sales Market Forecast by Region (2027-2032)
Figure 82. Global Long-acting GLP-1RA Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global Long-acting GLP-1RA Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global Long-acting GLP-1RA Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global Long-acting GLP-1RA Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global Long-acting GLP-1RA Revenue Market Share Forecast by Application (2027-2032)
